(Total Views: 251)
Posted On: 03/28/2019 4:27:57 PM
Post# of 227
NetworkNewsBreaks – Cannabis Strategic Ventures Inc. (NUGS) Cultivating Rich Portfolio to Grab Opportunity, Market Share
Los Angeles, California-based Cannabis Strategic Ventures (OTC: NUGS) is leveraging a diverse brand portfolio to grab opportunity and garner a corner of the $10 billion cannabis and $900 million hemp industries. A recent article discussing this reads, “One of its major subsidiaries, Pure Applied Sciences Inc., has cultivated a rich portfolio of ultra-high quality products. Its main brand is PureOrganix, a line of organic and pure cannabis oils and related accessories. The brand is responsible for noteworthy products like a ‘redefined’ vape pen made from environmentally friendly materials, which features 400 percent more battery power than similar offerings from competitors. All PureOrganix products, also including batteries and apparel, conform to the most stringent current good manufacturing practices (“cGMP”) and meet FDA guidelines for active pharmaceuticals ingredients (“API”), an achievement that most small companies find extremely difficult to attain.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Los Angeles, California-based Cannabis Strategic Ventures (OTC: NUGS) is leveraging a diverse brand portfolio to grab opportunity and garner a corner of the $10 billion cannabis and $900 million hemp industries. A recent article discussing this reads, “One of its major subsidiaries, Pure Applied Sciences Inc., has cultivated a rich portfolio of ultra-high quality products. Its main brand is PureOrganix, a line of organic and pure cannabis oils and related accessories. The brand is responsible for noteworthy products like a ‘redefined’ vape pen made from environmentally friendly materials, which features 400 percent more battery power than similar offerings from competitors. All PureOrganix products, also including batteries and apparel, conform to the most stringent current good manufacturing practices (“cGMP”) and meet FDA guidelines for active pharmaceuticals ingredients (“API”), an achievement that most small companies find extremely difficult to attain.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
